Environmental Issues in Pharmaceuticals
-
Upload
altaf-ur-rehman -
Category
Documents
-
view
221 -
download
0
Transcript of Environmental Issues in Pharmaceuticals
-
7/27/2019 Environmental Issues in Pharmaceuticals
1/21
Prepared By:- ALTAF URREHMAN
-
7/27/2019 Environmental Issues in Pharmaceuticals
2/21
Key Points
Of the total amount of waste generated by health-careactivities, about 80% is general waste.The remaining 20% is considered hazardous materialthat may be infectious, toxic or radioactive.Every year an estimated 16 000 million injections areadministered worldwide, but not all of the needles andsyringes are properly disposed of afterwards.Health-care waste contains potentially harmfulmicroorganisms which can infect hospital patients,
health-care workers and the general public.
-
7/27/2019 Environmental Issues in Pharmaceuticals
3/21
1) RESEARCH AND DEVELOPMENT,
2) CHEMICAL SYNTHESIS,
3) QC AND MICROBIOLOGY LAB
4) FORMULATION & PROCESS.
5) CONTAMINATED GLOVES, FILTERS, CLOTHINGS, ETC6) EXPIRED & RETURNED PRODUCTS AND CHEMICALS
-
7/27/2019 Environmental Issues in Pharmaceuticals
4/21
-
7/27/2019 Environmental Issues in Pharmaceuticals
5/21
-
7/27/2019 Environmental Issues in Pharmaceuticals
6/21
-
7/27/2019 Environmental Issues in Pharmaceuticals
7/21
-
7/27/2019 Environmental Issues in Pharmaceuticals
8/21
Dosage Forms Properties Uses
aromatic waters volatile solids or oils, water flavoring agents, carminative action
liquors or solutions water, chemicals internally or externally formulating aids
spirits, essences alcohol, water, volatile substances flavor or medicinal
syrups sweetener, solvent, medicinal agent flavoring agent, medicinal
suspensions
powder suspended in water, alcohol, glycol,or an oil; viscosity builders, wetting agents,preservatives oral dosing, skin application
ointments
hydrocarbon (oily), absorptivewaterwashable, or water-soluble bases;emulsifying agents; glycols; medicatingagent external
bulk powdercornminuted or blended, dissolved in ormixed with water external, internal
capsulessmall-dose bulk powder enclosed in gelatinshell; active ingredient plus diluent internal
tabletsmall molded tablets intended for quickcomplete dissolution oral
emulsions, lotions oil-in-water (o/w), or water-in-oil (w/o) Oral or external
-
7/27/2019 Environmental Issues in Pharmaceuticals
9/21
Waste type Origin Composition
Process liquors Organic syntheses Contaminated solvents
Spent fermentation broth Fermentation processes Contaminated water
Spent natural product Natural product Leaves, tissues
raw materials extraction processes
Spent aqueous solutions Solvent extraction processes Contaminated water
Leftover raw material containers Unloading of materials into process equipmentSags, drums (fiber, plastic, metal), plasticbottles
Scrubber water from Dust or hazardous vapor Contaminated water
pollution control equipment generating processes Solvents
Volatile organic compounds Chemical storage tanks, drums
Off-spec or out-dated products Manufacturing operations Miscellaneous products
Spills Manufacturing and lab operations Miscellaneous chemicals
Waste water Equipment cleaning, extraction residues Contaminated water
Spent solvents Solvent extraction or wash practices Contaminated solvents
Used production materials Manufacturing operations Filters, tubing, diatomaceous earth
Used chemical reagents R & D operations Miscellaneous chemicals
Packaging materials Packaging operationsRejected materials (plastics, glass, aluminiumetc.)Carbon compounds, oxides of nitrogen and
-
7/27/2019 Environmental Issues in Pharmaceuticals
10/21
Waste Stream Minimization Method
Containers Return empties to supplier
Thoroughly empty and triple rinse with minimal water
Use containers with recyclable liners
Segregate solid waste
Collect and reuse plastic from in-house molding
Air Emissions Control bulk storage air emissions (e.g. internal floating roofs).
Use dedicated dust collectors and rework dust back into product
Optimize fossil fuel combustion
Use dedicated vent condensers and return condensate to source, wherepossible
Maintain N2 purge rates at minimum through vapor space of agitatedreactors
-
7/27/2019 Environmental Issues in Pharmaceuticals
11/21
Equipment Cleaning Wastes Maximize number of campaigns to reduce cleaning frequency
Use final rinse as prerinse on next cleaning cycle
Use wiper blades and squeegees and rework remainders into products
Use low volume, high efficiency cleaning (e.g. spray heads)
Spills and Area Washdown Use dedicated vacuum systems
Use dry cleaning methods
Use recycled water
Off-spec Products Rework off-spec material
Use automated processing systems
Solvents Substitute aqueous systems where possible
Reduce quantity of solvent used
Regenerate/recover spent solven
Production Materials Validate cleaning and reuse
-
7/27/2019 Environmental Issues in Pharmaceuticals
12/21
Material SubstitutionProcess ModificationGood operating Practices
-
7/27/2019 Environmental Issues in Pharmaceuticals
13/21
E.g: Aqueous-based cleaning solutionsinstead of solvent-based solutionsReplacement of chlorinated solvents withnon-chlorinated solvents.
-
7/27/2019 Environmental Issues in Pharmaceuticals
14/21
Control Fouling deposits throughProper agitator designoptimization of operating temperatures
-
7/27/2019 Environmental Issues in Pharmaceuticals
15/21
PlantManagement
Managementincentives
Employeetraining
Closer supervision
Productionscheduling
Additionaldocumentation
-
7/27/2019 Environmental Issues in Pharmaceuticals
16/21
Waste
Management:
Waste/environmentalaudits
Waste streamsegregation
Waste handling andstorage procedures
-
7/27/2019 Environmental Issues in Pharmaceuticals
17/21
MaterialsHandling:
Materialstracking and
inventory control
Spill preventionMaterial handling
and storage
procedures
Preventivemaintenance
-
7/27/2019 Environmental Issues in Pharmaceuticals
18/21
IncinerationLandfillDisposed off RecycleReprocess
-
7/27/2019 Environmental Issues in Pharmaceuticals
19/21
MUNICIPAL WASTE SEWER SYSTEM CHEMO WASTE- SHARPS
CHEMO WASTE- SOFT RED SHARPS
Packaging Empty glass bottles Empty plastic bottles Paper Plastic Food waste, etc.
IVs - D5W- NaCl- Other?
Controlledsubstances?
Antibiotics?
Vials - Empty (trace)- Partial (residue)
Syringes/Needles - Empty- Unused, partial
IVs - Empty- Unused, partial
Spill clean up?
Gowns Gloves Goggles Tubing Wipes Spill clean up?
Vials - Empty- Partial
Syringes/Needles - Empty- Unused, partial
IVs - Empty- Unused, partial
LANDFILL ORMUNICIPAL INCINERATOR
WATERTREATMENT PLANT
Leachate intoground water or air emissions
Discharge tosurface waters
Leachate
Contents of Current Pharmaceutical Waste Streams
AUTOCLAVE/MICROWAVE
Shredded (?)
NON-HAZARDOUS LANDFILL
Ash
MEDICAL WASTE INCINERATOR
-
7/27/2019 Environmental Issues in Pharmaceuticals
20/21
Conclusions of Presentation (continued )
Landfills are most popular final disposaltechnique
Proper design of incinerators and landfills isimportant to fulfil the regulatory requirements
Proper planning, design, and operation are
the key points involved in the disposal of suchwaste
-
7/27/2019 Environmental Issues in Pharmaceuticals
21/21
Conclusions of Presentation
Treatment of pharmaceutical solid/gaseouswaste is important from health and safetyrelated properties
There is not much treatment of solidpharmaceutical waste. Most of the time solidwaste is disposed of
Disposal of solid pharmaceutical waste andelimination of the emissions from incinerator operations are very important to protect theland, water bodies and atmosphericenvironment